EX-23.1 2 xene-ex231_10.htm EX-23.1 xene-ex231_10.htm

 

Exhibit 23.1

 

 

 

 

 

 

 

 

 

KPMG LLP

 

Telephone

 

(604) 691-3000

 

 

Chartered Accountants

 

Fax

 

(604) 691-3031

 

 

PO Box 10426 777 Dunsmuir Street

 

Internet

 

www.kpmg.ca

 

 

Vancouver BC V7Y 1K3

 

 

 

 

 

 

Canada

 

 

 

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

The Board of Directors
Xenon Pharmaceuticals Inc.

We consent to the incorporation by reference in the registration statements (Nos. 333-199860, 333-202765, 333-210050 and 333-216543) on Form S-8 and (No. 333-208376) on Form S-3 of Xenon Pharmaceuticals Inc. of our report dated March 7, 2018, with respect to the consolidated balance sheets of Xenon Pharmaceuticals Inc. as of December 31, 2017 and December 31, 2016, and the related  consolidated statements of operations and comprehensive loss, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017, which report appears in the December 31, 2017 annual report on Form 10-K of Xenon Pharmaceuticals Inc.

 

/s/ KPMG LLP

Chartered Professional Accountants

 

March 7, 2018
Vancouver, Canada

 

KPMG LLP is a Canadian limited liability partnership and a member firm of the KPMG
network of independent member firms affiliated with KPMG International Cooperative
(“KPMG International”), a Swiss entity.
KPMG Canada provides services to KPMG LLP.